PCAP
AMPE

Pratt Collard Advisory Partners’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Pratt Collard Advisory Partners’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-52
Closed -$53K – 114
2018
Q1 		$53K Hold
52
– – 0.05% 110
2017
Q4 		$63K Buy
+52
New +$24.4K 0.05% 111

Other funds holding AMPE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
CCMW
Cypress Capital Management (Wyoming) Sheridan, Wyoming $108M AUM 54.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TW
Transform Wealth Greenwood Village, Colorado $1.65B AUM 19.1% 1-Year Est. Return

Pratt Collard Advisory Partners's AMPE Position: Q2 2018 in Review

Pratt Collard Advisory Partners sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q2 2018, closing a stake of 52 shares — an estimated $53K sold.

Pratt Collard Advisory Partners first reported a position in AMPE in Q4 2017 and held it in 2 quarters. The position peaked at $63K in Q4 2017. 86 funds tracked by Wall St. Rank hold AMPE as of Q2 2018.

  • Pratt Collard Advisory Partners reported no remaining Ampio Pharmaceuticals Inc. position as of Q2 2018 after selling out during the quarter.
  • Pratt Collard Advisory Partners sold 52 Ampio Pharmaceuticals Inc. shares in Q2 2018, an estimated $53K.
  • Pratt Collard Advisory Partners first reported a position in Ampio Pharmaceuticals Inc. in Q4 2017 and held it in 2 quarters.
  • Pratt Collard Advisory Partners's Ampio Pharmaceuticals Inc. position peaked at $63K in Q4 2017.
  • 86 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q2 2018.

Based on Pratt Collard Advisory Partners's 13F filing for Q2 2018, filed 25 Jul 2018.